Tattersall Mh
About
In The Last Decade
Tattersall Mh
18 papers receiving 418 citations
Hit Papers
Peers
Comparison fields: 5 of 67
- Oncology 306
- Clinical Biochemistry 174
- Pharmacology 119
- Epidemiology 88
- Emergency Medicine 83
Countries citing papers authored by Tattersall Mh
This map shows the geographic impact of Tattersall Mh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tattersall Mh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tattersall Mh more than expected).
Fields of papers citing papers by Tattersall Mh
This network shows the impact of papers produced by Tattersall Mh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tattersall Mh. The network helps show where Tattersall Mh may publish in the future.
Co-authorship network of co-authors of Tattersall Mh
This figure shows the co-authorship network connecting the top 25 collaborators of Tattersall Mh. A scholar is included among the top collaborators of Tattersall Mh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tattersall Mh. Tattersall Mh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | Concomitant and neoadjuvant chemotherapy in conjunction with radiotherapy in the management of locally advanced cervical cancer. | 5 |
| 3 | Achievable goals and relevant endpoints in cancer treatment. | 3 |
| 4 | Biochemical modulation of fluorouracil therapy in advanced colorectal cancer. | 4 |
| 5 | Characterization of conditions in which dipyridamole enhances methotrexate toxicity in L1210 cells. | 13 |
| 6 | Drug resistance in the clinical situation. | 2 |
| 7 | A simple and rapid method for the identification of cycling cells in freshly excised tumours. | 6 |
| 8 | Current studies of methotrexate and 5-fluorouracil and their interaction in human tumor cells. | 4 |
| 9 | Regional variation in human extracellular purine levels. | 24 |
| 10 | Phase II study of doxorubicin and mitomycin in non-small cell bronchogenic carcinoma. | 3 |
| 11 | Cost considerations in cancer chemotherapy. | 2 |
| 12 | Methotrexate treatment of advanced head and neck cancers: a dose response evaluation. | 11 |
| 13 | Combination chemotherapy with vincristine, bleomycin, and methotrexate for advanced head and neck cancers. | 5 |
| 14 | Treatment of small cell bronchogenic carcinoma with VM-26. | 20 |
| 15 | Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group. breakdown → | 351 |
| 16 | CB 10-252 in the treatment of primary hepatocellular carcinoma. | 2 |
| 17 | Aspects of the reversal of methotrexate toxicity in rodents. | 3 |
| 18 | Anticancer drugs: pharmacology and drug interactions. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.